Biological Plasticity, Cell Danger Signaling & Symptom Management: Where To Draw the Line?

There’s a fine balance between treatment and non-treatment. Philosophically I verge more on the side of conservative and “less is more treatment” for many reasons. My current philosophy in these regards is based upon the potential adverse effects of pharmaceuticals, and of the assault I believe many drugs have on memory-based physiological processes, also known

Neurosteroid Hormones & Multiple Sclerosis: A Viable Consideration for Men & Women

Neurosteroids are defined as any steroidal hormone that is permitted to enter the brain and nervous system, or can be produced by those cells. Estrogens, testosterone, progesterone, DHEA, cortisol, allopregnanolone are all neurosteroids, and as such confer potential therapeutic opportunities for neurodegenerative and deymyelinating diseases, such as multiple sclerosis. Scientific Evidence for Neurosteroid Use in

Circadian Biology & Parkinson’s Disease: The Clock is Ticking

Parkinson’s disease involves significant disruption to the circadian clock. A loss of normal clock gene expression leads to a desynchronization of fundamental biological and physiological processes. These findings open the door for circadian rhythm-based treatments for neurological diseases such as Parkinson’s. Parkinson’s disease is characterized as a loss of dopaminergic neurons within the substantia nigra

Breakthrough Research Presented on Joint Hypermobility Syndromes & The Extracellular Matrix

If you are a healthcare practitioner, join Metabolic Healing founder Michael McEvoy at the The Forum For Integrative Medicine Conference (TFIM) in Seattle, WA, March 7-9, 2019. Michael McEvoy is a researcher and clinician studying the breakthrough mechanisms of complex disease. Michael’s presentation is titled: Joint Hypermobility Syndromes & the Extracellular Matrix: Problems & Solutions.